Aptevo Therapeutics
(NASDAQ:APVO)
$3.865
0.095[2.52%]
Last update: 1:00PM
Day High/Low3.8 - 4.15
52 Week High/Low3.03 - 22.68
Open / Close3.88 / -
Float / Outstanding5M / 5M
Vol / Avg.51K / 94.9K
Mkt Cap19.4M
P/E-
50d Avg. Price4.25
Div / Yield-
Payout Ratio-
EPS-1.55
Total Float5M

Aptevo Therapeutics (NASDAQ:APVO), Quotes and News Summary

Aptevo Therapeutics (NASDAQ: APVO)

Day High/Low3.8 - 4.15
52 Week High/Low3.03 - 22.68
Open / Close3.88 / -
Float / Outstanding5M / 5M
Vol / Avg.51K / 94.9K
Mkt Cap19.4M
P/E-
50d Avg. Price4.25
Div / Yield-
Payout Ratio-
EPS-1.55
Total Float5M
Benzinga - Jun 13, 2022, 4:28AM
Sector: Health Care.Industry: Biotechnology
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-1.150-1.550 -0.4000
REV3.750M3.114M-636.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Aptevo Therapeutics Questions & Answers

Q
How do I buy Aptevo Therapeutics (APVO) stock?
A

You can purchase shares of Aptevo Therapeutics (NASDAQ: APVO) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Aptevo Therapeutics's (APVO) competitors?
Q
What is the target price for Aptevo Therapeutics (APVO) stock?
A

The latest price target for Aptevo Therapeutics (NASDAQ: APVO) was reported by Piper Sandler on Friday, May 13, 2022. The analyst firm set a price target for 20.00 expecting APVO to rise to within 12 months (a possible 417.46% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Aptevo Therapeutics (APVO)?
A

The stock price for Aptevo Therapeutics (NASDAQ: APVO) is $3.865 last updated Today at July 6, 2022, 5:00 PM UTC.

Q
Does Aptevo Therapeutics (APVO) pay a dividend?
A

There are no upcoming dividends for Aptevo Therapeutics.

Q
When is Aptevo Therapeutics (NASDAQ:APVO) reporting earnings?
A

Aptevo Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Aptevo Therapeutics (APVO) going to split?
A

There is no upcoming split for Aptevo Therapeutics.

Q
What sector and industry does Aptevo Therapeutics (APVO) operate in?
A

Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.